Somatic mutations in exons 3 or 13 of the PTPN11 gene are present in ~35% of JMML cases [22,31], resulting in a gain-of-function of the nonreceptor tyrosine phosphatase Shp2 [32]. This evidence concerns the gene PTPN11 and juvenile myelomonocytic leukemia.